NYSE:TEVAPublished
Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company
Teva's Pivot to Growth Strategy, R&D priorities, and expectations remain unchanged; Company initiates search for successor TEL AVIV, Israel and PARSIPPANY, N.J., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Dr.